Son, WS; Jeong, KS; Lim, SM; Pae, AN in [Son, Woo Seung; Lim, Sang Min; Pae, Ae Nim] Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment & Care Syst De, 5,Hwarang Ro 14 Gil, Seoul 02792, South Korea; [Son, Woo Seung; Jeong, Kyu-Sung] Yonsei Univ, Dept Chem, 50 Yonsei Ro, Seoul 03722, South Korea; [Lim, Sang Min; Pae, Ae Nim] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, 5,Hwarang Ro 14 Gil, Seoul 02792, South Korea published Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model in 2019.0, Cited 30.0. Recommanded Product: 500-22-1. The Name is 3-Pyridinecarboxaldehyde. Through research, I have a further understanding and discovery of 500-22-1.
Highly effective and safe drugs for the treatment of neuropathic pain are urgently required and it was shown that blocking T-type calcium channels can be a promising strategy for drug development for neuropathic pain. We have developed pyrrolidine-based T-type calcium channel inhibitors by structural hybridization and subsequent assessment of in vitro activities against Ca(v)3.1 and Ca(v)3.2 channels. Profiling of in vitro ADME properties of compounds was also carried out. The representative compound 17h showed comparable in vivo efficacy to gabapentin in the SNL model, which indicates T-type calcium channel inhibitors can be developed as effective therapeutics for neuropathic pain.
Recommanded Product: 500-22-1. About 3-Pyridinecarboxaldehyde, If you have any questions, you can contact Son, WS; Jeong, KS; Lim, SM; Pae, AN or concate me.
Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem